Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-06 4:34 pm Sale |
2025-02-28 | 13G | Net Lease Office Properties NLOP |
MORGAN STANLEY MS |
138,262 0.900% |
-842,530 (-85.90%) |
Filing History |
| 2025-03-06 4:28 pm Sale |
2025-02-28 | 13G | Sage Therapeutics, Inc. SAGE |
MORGAN STANLEY MS |
1,012,337 1.600% |
-3,530,655 (-77.72%) |
Filing History |
| 2025-03-06 4:18 pm Sale |
2025-02-28 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
MORGAN STANLEY MS |
0 0.000% |
-3,298,215 (Position Closed) |
Filing History |
| 2025-02-14 3:21 pm Purchase |
2024-12-31 | 13G | Theratechnologies Inc. THTX |
MORGAN STANLEY MS |
2,313,769 5.000% |
2,313,769 (New Position) |
Filing History |
| 2025-02-07 4:13 pm Sale |
2025-01-31 | 13G | Applied Therapeutics, Inc. APLT |
MORGAN STANLEY MS |
2,858,931 2.500% |
-5,956,595 (-67.57%) |
Filing History |
| 2025-02-07 12:37 pm Sale |
2024-12-31 | 13G | Envista Holdings Corp NVST |
MORGAN STANLEY MS |
14,141,070 8.200% |
-1,757,797 (-11.06%) |
Filing History |
| 2025-02-06 11:58 am Purchase |
2024-12-31 | 13G | TAL Education Group TAL |
MORGAN STANLEY MS |
8,908,863 5.800% |
1,490,971 (+20.10%) |
Filing History |
| 2025-02-05 2:09 pm Sale |
2024-12-31 | 13G | Virtus Total Return Fund Inc. ZTR |
MORGAN STANLEY MS |
1,671,707 2.700% |
-1,768,567 (-51.41%) |
Filing History |
| 2025-02-05 2:02 pm Sale |
2024-12-31 | 13G | U.S. Physical Therapy, Inc. USPH |
MORGAN STANLEY MS |
889,644 5.900% |
-149,773 (-14.41%) |
Filing History |
| 2025-02-05 1:51 pm Sale |
2024-12-31 | 13G | Sphere Entertainment Co. SPHR |
MORGAN STANLEY MS |
1,270,866 4.400% |
-782,116 (-38.10%) |
Filing History |
| 2025-02-05 1:44 pm Sale |
2024-12-31 | 13G | Cohen & Steers Real Estate Opportunities Income Fund RLTY |
MORGAN STANLEY MS |
679,684 4.100% |
-308,903 (-31.25%) |
Filing History |
| 2025-02-05 1:06 pm Sale |
2024-12-31 | 13G | Western Asset Inflation-Linked Opportunities & Income Fund WIW |
MORGAN STANLEY MS |
2,487,171 4.100% |
-2,053,853 (-45.23%) |
Filing History |
| 2025-02-05 10:46 am Purchase |
2024-12-31 | 13G | Western Asset Inflation-Linked Opportunities & Income Fund WIW |
MORGAN STANLEY MS |
4,541,024 7.400% |
182,866 (+4.20%) |
Filing History |
| 2025-02-05 10:43 am Purchase |
2024-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA |
MORGAN STANLEY MS |
17,629,264 8.600% |
17,629,264 (New Position) |
Filing History |
| 2025-02-05 10:41 am Purchase |
2024-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
MORGAN STANLEY MS |
4,542,992 7.400% |
4,542,992 (New Position) |
Filing History |
| 2025-02-05 10:38 am Sale |
2024-12-31 | 13G | Brookfield Real Assets Income Fund Inc. RA |
MORGAN STANLEY MS |
2,455,074 4.400% |
-1,268,631 (-34.07%) |
Filing History |
| 2025-02-05 10:23 am Purchase |
2024-12-31 | 13G | Western Asset Premier Bond Fund WEA |
MORGAN STANLEY MS |
1,538,313 13.000% |
133,391 (+9.49%) |
Filing History |
| 2025-02-05 10:10 am Purchase |
2024-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
MORGAN STANLEY MS |
1,157,140 6.200% |
1,157,140 (New Position) |
Filing History |
| 2025-02-05 10:09 am Sale |
2024-12-31 | 13G | UroGen Pharma Ltd. URGN |
MORGAN STANLEY MS |
752,861 1.800% |
-1,419,466 (-65.34%) |
Filing History |
| 2025-02-05 10:07 am Purchase |
2024-12-31 | 13G | Galaxy Next Generation, Inc. GAXYQ |
MORGAN STANLEY MS |
4,836,001 6.900% |
4,836,001 (New Position) |
Filing History |